Yaohua Wei

national center for nanoscience and technology

H指数:21

被引数:1,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predominant mutated non-canonical tumor-specific antigens identified by proteogenomics demonstrate immunogenicity and tumor suppression in CRC

Cell Genomics

IF9

2026-01-220

OAAI

Predominant mutated non-canonical tumor-specific antigens identified by proteogenomics demonstrate immunogenicity and tumor suppression in CRC

通过蛋白质组学鉴定出的主要突变非经典肿瘤特异性抗原显示出免疫原性和结直肠癌抑制作用。

Cell Genomics

IF9

2025-11-130

OAAI

Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss

脂质体清除衰老药物靶向递送以缓解细胞衰老诱导的骨丢失

Fundamental Research

IF6.3

2024-12-270

OAAI

Stimuli-Responsive Polymersomes: Reshaping the Immunosuppressive Tumor Microenvironment

BIOMACROMOLECULES

IF5.4

2024-07-265

PRE

The challenge and opportunity of gut microbiota-targeted nanomedicine for colorectal cancer therapy

肠道菌群靶向纳米药物治疗结直肠癌的挑战与机遇

IMETA

IF33.2

2024-06-100

OAAI

α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment (vol 12, pg 14905, 2020)

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-05-210

Delivery of neutrophil membrane encapsulated non-steroidal anti- inflammatory drugs by degradable biopolymer microneedle patch for rheumatoid arthritis therapy

NANO TODAY

IF10.9

2023-04-0120

PRE

Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis

ADVANCED SCIENCE

IF14.1

2022-12-1818

Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers (vol 23, pg 100, 2022)

西妥昔单抗-聚合物-Mertansine纳米药物用于EGFR阳性癌症的有效和靶向治疗 (第23卷，100页，2022)

BIOMACROMOLECULES

IF5.4

2022-11-090

PRE

Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers

BIOMACROMOLECULES

IF5.4

2021-12-1616

PREAI

Construction of a Degradation-Free DNA Conjugated Nanoprobe and Its Application in Rapid Field Screening for Sulfur Mustard

ANALYTICAL CHEMISTRY

IF6.7

2021-12-075

PREAI

Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo

JOURNAL OF CONTROLLED RELEASE

IF11.5

2021-09-0142

OAAI

GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma

ACTA BIOMATERIALIA

IF9.6

2020-09-0135

OAAI

α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment

靶向 α3β1整联蛋白的聚合物体多西他赛作为非小细胞肺癌治疗的先进纳米治疗剂

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2020-03-0929

OAAI

Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo

转铁蛋白结合肽功能化聚合物囊泡介导阿霉素靶向递送至体内结直肠癌

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-03-0179

OAAI

Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma

BIOMACROMOLECULES

IF5.4

2019-12-0625

PREAI

Nanoagents Based on Poly(ethylene glycol)-b-Poly(l-thyroxine) Block Copolypeptide for Enhanced Dual-Modality Imaging and Targeted Tumor Radiotherapy

SMALL

IF12.1

2019-09-2020

PREAI

Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo

ACTA BIOMATERIALIA

IF9.6

2019-07-0147

OAAI

Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors

选择性细胞穿透肽功能化的包膜型嵌合脂质脂质体促进肺部肿瘤的全身RNAi治疗

ADVANCED HEALTHCARE MATERIALS

IF9.6

2019-06-2436

PREAI

Iodine-Rich Polymersomes Enable Versatile SPECT/CT Imaging and Potent Radioisotope Therapy for Tumor in Vivo

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2019-05-0742

PREAI

Yaohua Wei

个人简介

教育背景

工作经历

荣誉奖项

研究方向